All In Biotech

Drug Trial Radar · NCT07702578

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

A Phase 1/3 Study Evaluating the Efficacy and Safety of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

310

Planned (sponsor's estimate)

Start

Jun 18, 2026

Primary completion

Jun 2029

Study completion Jun 2029

Sponsor

Lead sponsor
TScan Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, genetically-randomized, controlled, Phase 3 study evaluating the efficacy and safety of T-cell receptor-engineered donor T cells targeting HA-2 (TSC-101) administered following reduced-intensity conditioning (RIC) hematopoietic cell transplantation (HCT) in participants with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The study will compare TSC-101 plus standard of care (SOC) versus SOC alone in participants undergoing allogeneic peripheral blood stem cell transplantation from haploidentical or mismatched unrelated donors.

Conditions

  • AML
  • MDS

Interventions

  • TSC-101Drug

    SOC + TSC-101

  • ControlOther

    SOC alone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relapse-free survival (RFS)Time frame: 3 years

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Health - MD Anderson Cancer Center

    Gilbert, Arizona

  • Honor Health Cancer Transplant Institute

    Scottsdale, Arizona

  • City of Hope

    Duarte, California

  • Stanford - School of Medicine

    Stanford, California

  • University of Colorado - Anschutz Cancer Center

    Aurora, Colorado

  • SCRI - Colorado Blood Cancer Institute

    Denver, Colorado

  • Yale

    New Haven, Connecticut

  • Memorial Cancer Institute

    Hollywood, Florida

  • Moffitt Cancer Institute

    Tampa, Florida

  • Northside Hospital

    Atlanta, Georgia

  • University of Chicago

    Chicago, Illinois

  • The University of Kansas Cancer Center

    Kansas City, Kansas

  • Johns Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Dana-Farber Cancer Institute - Hematology/Oncology

    Boston, Massachusetts

  • Karmanos Cancer Institute

    Detroit, Michigan

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Mount Sinai Hospital

    New York, New York

  • Columbia University - Irving Medical Center

    New York, New York

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Sarah Cannon Research Institute - TriStar Bone Marrow Transplant (BMT)

    Nashville, Tennessee

  • St. David's South Austin Medical Center

    Austin, Texas

  • Baylor University Medical Center

    Dallas, Texas

  • The University of Texas - MD Anderson Cancer Center

    Houston, Texas

  • Froedtert & Medical College of Wisconsin

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.